ArticleJournal of Cancer2021

RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.

Sung-Hwa Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.